Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Clearwater Paper
CLW
$359M
| $3.19M | ﹤0.01% |
84,300
-14,700
| -15% | -$573K |
|
|
GIFI
1777
DELISTED
Gulf Island Fabrication
GIFI
| $3.19M | ﹤0.01% |
621,280
-23,644
| -4% | -$114K |
|
1778
Protolabs
PRLB
$1.92B
| $3.18M | ﹤0.01% |
124,700
-13,700
| -10% | -$407K |
|
1779
Adaptive Biotechnologies
ADPT
$3.9B
| $3.18M | ﹤0.01% |
415,800
-42,000
| -9% | -$327K |
|
|
DAWN
1780
DELISTED
Day One Biopharmaceuticals
DAWN
| $3.17M | ﹤0.01% |
147,426
+49,526
| +51% | +$1.02M |
|
|
CBAY
1781
DELISTED
Cymabay Therapeutics
CBAY
| $3.17M | ﹤0.01% |
505,900
+15,100
| +3% | +$57.4K |
|
1782
Travelers Companies
TRV
$78B
| $3.17M | ﹤0.01% |
+16,900
| New | +$3.04M |
|
1783
Jabil
JBL
$33.4B
| $3.16M | ﹤0.01% |
46,273
-91,727
| -66% | -$6.06M |
|
1784
Organogenesis Holdings
ORGO
$305M
| $3.16M | ﹤0.01% |
1,173,398
-9,602
| -0.8% | -$28K |
|
1785
Natural Alternatives International
NAII
$14.2M
| $3.14M | ﹤0.01% |
374,598
-19,300
| -5% | -$161K |
|
|
MIXT
1786
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $3.14M | ﹤0.01% |
446,800
-59,252
| -12% | -$460K |
|
1787
Patria Investments
PAX
$1.8B
| $3.13M | ﹤0.01% |
224,900
+27,500
| +14% | +$372K |
|
1788
Rio Tinto
RIO
$161B
| $3.12M | ﹤0.01% |
43,800
-77,900
| -64% | -$4.89M |
|
1789
MGP Ingredients
MGPI
$370M
| $3.12M | ﹤0.01% |
29,300
+1,100
| +4% | +$123K |
|
1790
Waters Corp
WAT
$36.8B
| $3.12M | ﹤0.01% |
9,100
-1,700
| -16% | -$538K |
|
|
ITIC
1791
Investors Title Co
ITIC
$551M
| $3.11M | ﹤0.01% |
21,100
-900
| -4% | -$131K |
|
1792
OneSpaWorld
OSW
$2.68B
| $3.11M | ﹤0.01% |
333,182
+203,982
| +158% | +$1.93M |
|
1793
Rocket Pharmaceuticals
RCKT
$376M
| $3.11M | ﹤0.01% |
158,800
-321,000
| -67% | -$5.91M |
|
1794
First Advantage
FA
$3.5B
| $3.11M | ﹤0.01% |
239,000
-65,800
| -22% | -$859K |
|
1795
Lincoln Educational Services
LINC
$1.37B
| $3.11M | ﹤0.01% |
536,478
-37,100
| -6% | -$219K |
|
|
XRN
1796
Chiron Real Estate Inc
XRN
$467M
| $3.1M | ﹤0.01% |
65,450
-34,350
| -34% | -$1.55M |
|
|
ESGR
1797
DELISTED
Enstar Group
ESGR
| $3.1M | ﹤0.01% |
13,400
-11,000
| -45% | -$2.24M |
|
1798
Mueller Water Products
MWA
$4.04B
| $3.1M | ﹤0.01% |
+287,700
| New | +$3.21M |
|
|
VBTX
1799
DELISTED
Veritex Holdings
VBTX
| $3.1M | ﹤0.01% |
110,223
-8,386
| -7% | -$249K |
|
1800
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.63B
| $3.09M | ﹤0.01% |
+79,400
| New | +$3.12M |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.